Abstract
MO35-1 Prognostic evolution of EGFR-mutated non-small cell lung cancer over the past 20 years since the beginning with gefitinib
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date